Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA vaccines

J B Ulmer1, J C Sadoff, M A Liu

  • 1Department of Virus & Cell Biology, Merck Research Laboratories, WP 16-101, West Point, PA 19486, USA. jeff_ulmer@merck.com

Current Opinion in Immunology
|August 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DNA vaccines.

Methods in molecular medicine·2011
Same author

The second Geneva Consensus: Recommendations for novel live TB vaccines.

Vaccine·2010
Same author

Public health. The cholera crisis in Africa.

Science (New York, N.Y.)·2009
Same author

Topic in Review: Vaccines in the 21st century.

The Western journal of medicine·2008
Same author

Pre-clinical evaluation of a CEA DNA prime/protein boost vaccination strategy against colorectal cancer.

Scandinavian journal of immunology·2007
Same author

Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8+ T-cell response in patients with pulmonary tuberculosis.

Genes and immunity·2007
Same journal

A blind spot of human T cell immunology: epitope specificity in secondary lymphoid organs.

Current opinion in immunology·2026
Same journal

Germinal center responses at barrier organ sites.

Current opinion in immunology·2026
Same journal

Ocular sarcoidosis: from clinical signs to targeted interventions.

Current opinion in immunology·2026
Same journal

On or within: spatial determinants of antigen handling in the nasal turbinates.

Current opinion in immunology·2026
Same journal

Decoding the complexity of intestinal immunity with spatial transcriptomics.

Current opinion in immunology·2026
Same journal

Reconsidering the immunological aspects of solid-phase assays for antiphospholipid antibodies detection.

Current opinion in immunology·2026
See all related articles

Preclinical DNA vaccine development shows progress in targeting various diseases and understanding immune responses. Initial human clinical studies are now underway, marking an exciting new phase for DNA vaccine research.

Area of Science:

  • Immunology
  • Vaccinology
  • Molecular Biology

Background:

  • Preclinical DNA vaccine development has advanced significantly over the past year.
  • Research has explored novel infectious and non-infectious disease targets for DNA vaccines.

Purpose of the Study:

  • To summarize recent progress in preclinical DNA vaccine development.
  • To highlight advances in understanding the immunological mechanisms of DNA vaccine-induced protection.
  • To note the commencement of human clinical studies.

Main Methods:

  • Review of preclinical research and immunological studies.
  • Investigation of various disease targets.
  • Analysis of immune effector mechanisms.

Main Results:

Related Experiment Videos

  • Significant progress in preclinical DNA vaccine development for diverse disease targets.
  • Enhanced understanding of immune mechanisms, including the role of effector cells, in conferring protection.
  • Initiation of human clinical trials.

Conclusions:

  • The field of DNA vaccine development is rapidly advancing.
  • The transition to human clinical studies signifies a critical milestone.
  • Continued research promises further breakthroughs in vaccine efficacy and application.